Cabotegravir
Back to searchMolecule Structure
Scientific Name
Cabotegravir
Description of the Drug
Cabotegravir is an HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11751
http://www.drugbank.ca/drugs/DB11751
Brand Name(s)
Apretude
Company Owner(s)
Viiv Healthcare Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 integrase | SINGLE PROTEIN | INHIBITOR | CHEMBL3471 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL82803 |
| DrugBank | DB11751 |
| PubChem: Thomson Pharma | 17424254 |
| PubChem | 54713659 |
| Nikkaji | J3.144.828J |
| BindingDB | 50492496 |
| EPA CompTox Dashboard | DTXSID50146982 |
| DrugCentral | 5440 |
| ChemicalBook | CB02668664 |
| ChEBI | 172944 |
| ZINC | ZINC000096927633 |
